All Brands Owned by SERB Pharmaceuticals
SERB Pharmaceuticals owns 1 brand in our database. Browse the complete portfolio of SERB Pharmaceuticals subsidiaries and brands across various industries.
Company Type
private
Headquarters
Paris, France
Brand Portfolio
1 brands
Filter by Category
Showing Healthcare & Pharmaceuticals brands
1 of 1 total brands
Healthcare & Pharmaceuticals Brands
About SERB Pharmaceuticals
Who owns SERB Pharmaceuticals?
SERB Pharmaceuticals is a privately held company. Jeremie Urbain serves as chairman. The company does not publicly disclose its shareholder structure, and it is not owned by a larger pharmaceutical corporation.
Is SERB Pharmaceuticals publicly traded?
No. SERB is a private company. Its shares do not trade on any stock exchange.
When was SERB founded?
The original SERB (Société d'Études et de Recherches Biologiques) was founded in Paris in 1951. The modern company took shape through the 2021 acquisition of BTG Specialty Pharmaceuticals and a 2022 rebrand unifying SERB, BTG Specialty Pharmaceuticals, and Veriton Pharma.
Who makes Voraxaze?
Voraxaze (glucarpidase) is made by SERB Pharmaceuticals. SERB acquired the product in March 2021 as part of its approximately $800 million purchase of BTG Specialty Pharmaceuticals from Boston Scientific. BTG had originally launched Voraxaze in 2012.
What does SERB Pharmaceuticals make?
More than 70 medicines across two franchises: emergency medicine and antidotes (CroFab, DigiFab, Voraxaze, Radiogardase, and CBRN countermeasures) and rare disease treatments in oncology, neurology, and metabolic disorders, including Danyelza.
Where is SERB based?
The company is headquartered in Paris, France. Its US operations run through BTG Pharmaceuticals in West Conshohocken, Pennsylvania, and it has manufacturing and R&D sites in Wales, Australia, Utah, and France.
Competitors to SERB Pharmaceuticals
No competing brands found in the same categories. This could be because SERB Pharmaceuticalsoperates in unique market segments or we're still building our competitor database.
SERB Pharmaceuticals Brand Portfolio Overview
SERB Pharmaceuticals maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 1 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by SERB Pharmaceuticalsprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at SERB Pharmaceuticals
Latest News About SERB Pharmaceuticals
Articles About SERB Pharmaceuticals
View more articles
Health
Dental Brand Ownership Beyond Colgate and Crest
Colgate holds 41.3% global toothpaste share. P&G (Crest, Oral-B) has 14.1%. Haleon (Sensodyne) has 4.4%. Church & Dwight is the only independent at scale. The oral care market is $47.2B. Explore our database.
Who Brands StaffNov 12, 2026
ColgateCrestOral B
Health
Health Insurance Brand Ownership: The Big Players
UnitedHealth is #1 ($112B Q2 revenue, 26% MA share). CVS/Aetna is #3 ($106.1B Q2). Humana is #2 in MA (19.8%). Elevance is #2 by enrollment. Discover health insurance brand ownership. Explore our database.
Who Brands StaffNov 11, 2026
UnitedhealthAetnaCvs Health
Health
Organic Food Brand Ownership: Still Independent?
Annie's is General Mills ($820M). Cascadian Farm is General Mills (since 1999). Stonyfield is Lactalis (via Danone, $875M). Kashi is Kellogg's. Honest Tea was Coca-Cola (discontinued). Explore our database.
Who Brands StaffNov 9, 2026
Organic FoodAnniesCascadian Farm